Skip to main content
logo
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
55.62
+0.75 (1.37%)
At close: Sep 15, 2025, 4:00 PM EDT
56.03
+0.41 (0.74%)
After-hours: Sep 15, 2025, 7:59 PM EDT

Novo Nordisk Revenue

Novo Nordisk had revenue of 76.86B DKK in the quarter ending June 30, 2025, with 12.93% growth. This brings the company's revenue in the last twelve months to 311.94B, up 20.90% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

Revenue (ttm)
311.94B DKK
Revenue Growth
+20.90%
P/S Ratio
5.06
Revenue / Employee
4,032,864 DKK
Employees
77,349
Market Cap
248.69B USD

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Thermo Fisher Scientific43.21B
Revenue Rankings

NVO News

More News